Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
In fact, the 2018 midterm elections could be pivotal for the legalization of cannabidiol, commonly known as CBD, a component of the cannabis plant that is not psychoactive and widely used in medical marijuana products, Sands said.
"We expect [CBD] to become legalized potentially as soon as shortly after this election because there's a provision in the farm bill that will actually legalize CBD, the non-psychoactive component," Sands told "Mad Money" host in an exclusive interview.
Sands, whose alcohol distributor boasts popular brands including Corona and Modelo, said Constellation will work with Canopy on non-alcoholic cannabis drinks that resemble beer, champagne, spirits, water and tea.
"I think you'll see a lot of beverages introduced, probably non-alcoholic or in, I would say, most cases, non-alcoholic, to take advantage of at least the CBD legalization," the CEO said.
And while products containing tetrahydrocannabinol, or THC, could still be several years out from hitting U.S. shelves, Sands said the political scene was becoming more accepting to the idea of what could be a several hundred-billion-dollar industry.
"THC-containing cannabis, that's going to be some time off, but I would say that the political front is developing very quickly there," he told Cramer. "In the United States, we believe that it's an inevitability that cannabis will be decriminalized at the federal level. And, as we already know, a lot of states have legalized it recreationally."
Beyond that, Constellation's stake in Canopy allows the beverage producer to "play in" international markets that have moved faster on cannabis legalization than the United States, Sands said.
"You shouldn't lose sight of the international opportunity. There's huge countries — UK is looking at medical legalization. Germany has already legalized medical marijuana," the CEO said. "These are all places, given our Canopy investment, that we can play in. We think it's important to be able to play in all channels and in all segments, not just beverages and not just recreational."
Shares of Constellation Brands surged 5.38 percent on Thursday after the company well above Wall Street's expectations and raised its full-year forecast. The stock settled at $222.10 a share.